| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871478 | The Annals of Thoracic Surgery | 2016 | 7 Pages |
Abstract
The location of cN+ regional node disease in patients with distal esophageal or GEJ adenocarcinoma was not predictive of survival after trimodality therapy. Age, sex, pathologic tumor depth, and the number of involved nodes were independent predictors of survival. Patients with cN+ cancers should not be deprived of potentially curative surgical resection based solely on the location of regional nodal disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Boris MD, Henner E. MD, Michal MD, Arlene M. PhD, Garrett L. MD, Reza J. MD, David C. MD, Jack A. MD, Ara A. MD, Jaffer A. MD, Thomas J. MD, Stephen G. MD, Donald E. MD, Wayne L. MD,